MASLD: a disease in flux

Simple item page
dc.contributor.authorAllen, Alina M.
dc.contributor.authorArab, Juan Pablo
dc.contributor.authorWong, Vincent Wai-Sun
dc.date.accessioned2025-01-20T16:07:37Z
dc.date.available2025-01-20T16:07:37Z
dc.date.issued2024
dc.description.abstractTo coincide with the 20th anniversary of Nature Reviews Gastroenterology & Hepatology, we asked three experts to reflect on the past, present and future of metabolic dysfunction-associated steatotic liver disease (MASLD) research and clinical management. They comment on how MASLD research and clinical management has changed over the past 20 years, the strengths and limitations of the MASLD field today, and their predictions for progress over the next 20 years.
dc.description.abstractIn this Viewpoint, Alina M. Allen, Juan Pablo Arab and Vincent Wai-Sun Wong reflect on the past, present and future of metabolic dysfunction-associated steatotic liver disease (MASLD) research and clinical management.
dc.fuente.origenWOS
dc.identifier.doi10.1038/s41575-024-00990-5
dc.identifier.eissn1759-5053
dc.identifier.issn1759-5045
dc.identifier.urihttps://doi.org/10.1038/s41575-024-00990-5
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/90010
dc.identifier.wosidWOS:001324512700003
dc.issue.numero11
dc.language.isoen
dc.pagina.final750
dc.pagina.inicio747
dc.revistaNature reviews gastroenterology & hepatology
dc.rightsacceso restringido
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleMASLD: a disease in flux
dc.typeartículo
dc.volumen21
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas